Medical device registration in Spain is a multi-step process rather than a single application. It requires manufacturers to meet both EU conformity assessment requirements and Spain’s national obligations. Spain’s national commercialisation system was significantly updated in June 2026 with the introduction of the RECOPS platform. Read on for a step-by-step overview of the latest registration requirements in Spain.
This article covers Spain Medical Device Classification, CE Marking for Medical Devices in Spain, the Spain Medical Device Registration Process, import requirements and post-market obligations, basically everything a manufacturer needs to plan an accurate market entry.
Regulatory Authorities for Medical Devices in Spain
AEMPS is Spain’s competent authority for medical devices, and it operates under Royal Decree 192/2023. As an agency of the Ministry of Health, it is responsible for market surveillance, commercialisation notifications, manufacturing and import licences, clinical investigation authorisations, and vigilance activities.
But AEMPS doesn’t operate in isolation. Above that the EU-level infrastructure applies across all member states. EUDAMED holds the central registration data for economic operators, devices, and certificates. As of 28 May 2026, four EUDAMED modules, actor registration, UDI/device registration, notified bodies and certificates, and market surveillance, became mandatory across the EU.
The NANDO database provides an official list of notified bodies authorized to carry out conformity assessments. Spain also has a notified body that has been designated by the Ministry of Health. This is the Centro Nacional de Certificación de Productos Sanitarios (CNCps), identification number 0318, which operates under AEMPS.
Regional authorities in Spain are responsible for distributor notifications and certain establishment-level authorizations. Under Royal Decree 192/2023, they work alongside AEMPS to maintain registries and carry out market surveillance.
Spain Medical Device Classification
Spain does not use a separate national classification system for medical devices. The classification system is based on EU MDR Annex VIII. Depending on the level of risk, devices are assigned to Class I, IIa, IIb, or III. Some Class I devices receive the additional Is, Im or Ir designation based on their characteristics.
| Class | Risk | Examples |
| Class I | Low |
Bandages, Manual wheelchairs, Stethoscopes
|
| Class Is/Im/Ir | Low, with conditions |
Sterile gloves, Graduated urine bags, Reprocessed surgical tools
|
| Class IIa | Medium-low |
Hearing aids, Dental filings, Short-term catheters
|
| Class IIb | Medium-high |
Ventilators, Defibrillators, Long term implants
|
| Class III | High |
Pacemakers, Breast implants, Coronary stents
|
22 classification rules exist in Annex VIII. When more than one rule applies to a device, the highest applicable risk class applies. If a manufacturer established in Spain and its notified body disagree on a device’s classification, AEMPS resolves the dispute in accordance with MDR Article 51.
Authorized Representative (AR) Requirements in Spain
Manufacturers based outside the EU must appoint an EU Authorized Representative (AR) before beginning the regulatory process. As required by MDR Article 11, the AR must be a legal entity established within the EU and acts as the manufacturer’s official contact with AEMPS and other competent authorities. The AR’s name and address must also appear on the device label.
Manufacturers established in Spain or another EU Member State do not need an EU Authorized Representative. Spain also does not require a separate Spanish-language representative in addition to the EU Authorized Representative.
Medical Device Regulatory Guidelines in Spain
Medical device regulation in Spain is shaped by both EU legislation and Spanish national law. The main regulatory sources are listed below.
- Regulation (EU) 2017/745 (MDR): It is the primary EU legislation which defines the regulatory requirements that apply to medical devices throughout the European Union.
- Regulation (EU) 2017/746 (IVDR): It sets out the regulatory requirements for in vitro diagnostic medical devices across the EU.
- Royal Decree 192/2023: Spain’s national rules covering market oversight, establishment licences, language requirements, and commercialisation.
- Royal Decree 942/2025: Applies similar national provisions to in vitro diagnostic medical devices.
- Law 29/2006: The overarching Spanish law for medicines and health products.
- MDCG Guidance Documents: EU guidance that supports implementation of the MDR and IVDR.
- AEMPS Guía 2025: A practical reference published by AEMPS for economic operators.
Medical Device Registration Process in Spain
The Spain Medical Device Registration Process is not a single submission. It runs in parallel across EU-level and national-level obligations. Below is a practical step by step breakdown.
Step 1: Classify the device
The first step is to identify the device risk class under EU MDR Annex VIII. This single decision carries a lot of weight, since it affects notified body involvement, post-market surveillance obligations, documentation requirements and national notification procedures in Spain. Misclassification is one of the most common and costly early errors.
Step 2: Appoint an EU AR
Non-EU manufacturers must appoint and formally contract with an EU AR before any regulatory submission. The AR’s details must be included in EUDAMED and on the device label. This step must come before EUDAMED registration.
Step 3: Build the technical documentation
The next step is to prepare the technical documentation required by EU MDR Annexes II and III. All device classes require the same technical documentation under MDR Annexes II and III. The difference by class is who reviews it, manufacturers self-certify for most Class I devices, while a notified body reviews the documentation for Class IIa, IIb, and III. Documentaion can includes device description, specifications, design and manufacturing information, risk management records, clinical evaluation report, and post-market surveillance plan. And whatever’s submitted to AEMPS needs to be in Spanish, though authorities may accept supporting documentation in other languages.
Step 4: Select and Engage a Notified Body (Classes IIa, IIb, III)
For all device classes above Class I, a notified body listed on the NANDO database must be engaged. The notified body performs the conformity assessment. The timeline at this stage depends entirely on the notified body’s workload and the completeness of your submission.
Step 5: Register in EUDAMED
A Single Registration Number from EUDAMED has to be in hand before any device reaches the market. Device and UDI (Unique Device Identification) data then must be uploaded to the EUDAMED UDI/Device module. For new devices, as of May 2026, EUDAMED registration is required before market placement. EUDAMED registration covers the entire EU, including Spain.
Step 6: Affix CE Marking and Issue Declaration of Conformity
Once conformity assessment is complete, the manufacturer draws up the EU Declaration of Conformity. The CE mark is then affixed to the device, its packaging and any accompanying documentation, where applicable. For Class I devices, this step follows self-certification. For higher classes, it follows notified body certification. The CE mark is the prerequisite for the next step.
Step 7: Notify AEMPS through RECOPS
Before first placing Class I, IIa, IIb, or III devices on the Spanish market, submit a notification through the AEMPS RECOPS application. The notification includes the product’s trade name, the commercialisation start date, labeling and instructions for use. Product, manufacturer and certificate data is pulled automatically from EUDAMED rather than submitted separately.
Manufacturers of custom-made devices established in Spain, and their Spain-established authorized representatives, register separately through RPS.
Step 8: Apply for an operating licence (Importers and Manufacturers)
Manufacturers and importers established in Spain must obtain an operating licence from AEMPS before carrying out any activities. Licences are valid for a maximum of five years. Importers physically bringing devices into Spain from outside the EU must also hold an import licence.
Step 9: Maintain the Commercialisation Registry (Annual Updates)
RECOPS, the AEMPS Commercialisation Registry, is now operational. Registered economic agents must update their listings annually, confirming which products continue to be marketed. Failure to update results in removal of both the products and the economic agent from the registry.
Required Documents for Medical Device Registration in Spain
AEMPS notifications and underlying technical files generally need:
- Identifying information for the manufacturer, importer or AR
- Device trade name and model details
- Intended purpose and description
- Manufacturing location and manufacturer identification
- Notified body number and CE certificate (retrieved automatically from EUDAMED, not submitted separately), for Class IIa and above.
- EU Declaration of Conformity
- Technical documentation, with Spanish translation where AEMPS will review it
- Clinical Evaluation Report
- Documented quality management system, typically demonstrated through ISO 13485:2016 certification, for Classes IIa, IIb, III
- Risk management documentation, typically demonstrated through ISO 14971 certification
- Spanish labelling and IFU samples
- UDI assignment confirmation tied to EUDAMED
Documentation submitted to AEMPS on request must be in Spanish, though authorities may accept supporting materials in other languages as per Royal Decree 192/2023, Article 23.1.a.
QMS Requirements for Medical Devices in Spain
For Class IIa, IIb, and III devices, manufacturers are expected to maintain a quality management system (QMS) that is based on ISO 13485:2016. Notified bodies evaluate it during conformity assessment.
Formal QMS certification is not mandatory for Class I non-sterile devices under the MDR. But manufacturers are still expected to implement and document quality processes. AEMPS may request this documentation as part of its market surveillance activities.
UNE, Spain’s national standards body, has adopted the international standard as UNE-EN ISO 13485 which is technically identical to ISO 13485:2016 The QMS needs to cover design controls, production, risk management (tied to ISO 14971), post-market surveillance, and complaint handling.
Based on industry experience, many manufacturers place less emphasis on documenting complaint handling than other quality system processes. As a result, it is where the audits end up spending the most time.
Medical Device Labeling & IFU Requirements in Spain
Spanish-language labelling and Instructions for Use are mandatory before placing a device on the Spanish market. Spanish-language labelling and Instructions for Use aren’t optional. Manufacturers have to place them before a device touches the Spanish market, AEMPS pays particular attention to whether the Spanish content is actually readable by the intended user.
Mandatory label content under MDR Article 10(11) and Annex I includes:
- Device name and model
- Manufacturer name and address
- EU AR details, for non-EU manufacturers
- Batch/serial number
- Production and expiry dates, where relevant
- UDI carrier
Electronic IFUs are permitted in limited cases under Implementing Regulation (EU) 2021/2226, as revised by Implementing Regulation (EU) 2025/1234, but a free paper copy still has to be available on request.
Registration Timelines for Medical Devices in Spain
Timelines for the Spain Medical Device Registration Process depend primarily on device class and notified body workload. Neither the MDR nor Spanish regulation sets a fixed maximum for these steps, so the ranges below reflect industry experience rather than a legal deadline.
- Class I devices: No notified body involvement is required. AEMPS notification through RECOPS is the main remaining step. Manufacturers commonly report a total timeline in the range of a few weeks to a couple of months.
- Class IIa devices: Notified body conformity assessment is the main driver of timing. Industry estimates commonly put this in the range of several months, often three to nine, though this varies by notified body and workload.
- Class IIb devices: Conformity assessment tends to run longer than Class IIa, industry estimates often cite six to twelve months, again dependent on the specific notified body.
- Class III devices: This is typically the longest path, industry estimates often run from a year to two years, driven by the depth of clinical evidence review.
Actual timelines vary with notified body capacity and how complete the documentation package is on first submission. Incomplete technical files are widely cited across the industry as the most common cause of delay, though this too is drawn from market experience rather than a published AEMPS or EU statistic.
Medical Device Registration Costs in Spain
A commercialisation notification fee applies to each product under AEMPS fee schedule. Notified body fees are charged separately and depend on the device and conformity assessment required.
Other common expenses include AEMPS establishment licence fees, translation of documentation into Spanish, EUDAMED registration preparation, EU Authorized Representative fees for non-EU manufacturers, and ISO 13485 certification. Since these costs vary from one product to another, the overall investment depends on the device’s classification and regulatory requirements.
Import Requirements for Medical Devices in Spain
Spain’s medical device import requirements include a national licensing obligation for importers. Any company physically importing medical devices into Spain from outside the EU must obtain an operating licence issued by AEMPS. And this applies even when the importer is also the manufacturer, if manufacturing happens outside the EU and the finished product is physically imported into Spain.
Importers established in Spain must also meet standard EU MDR duties under Article 13. These include verifying CE conformity, checking device labelling and confirming that an EU Authorized Representative has been properly appointed where required.
Distributors, under Article 14, have a separate, lighter notification duty to their relevant regional health authority.
Post-Market Surveillance Requirements in Spain
Post-market obligations track EU MDR closely, with AEMPS doing the active supervision on the Spanish side. Manufacturers must maintain a post-market surveillance (PMS) system that supports updates to the clinical evaluation, risk management documentation, and technical documentation. PSURs must be prepared annually for Class IIb and III devices and every two years for Class IIa devices.
Vigilance reporting timelines:
- Serious incidents: Must be reported within 15 days under MDR Article 87.
- Serious public health threats: Must be reported within 2 days under MDR Article 87.
- Deaths or unanticipated serious deterioration in health: Must be reported within 10 days under MDR Article 87.
Under Royal Decree 192/2023, Article 35, healthcare professionals and public authorities who become aware of a serious incident must report it to AEMPS through the NotificaPS portal.
Since 10 January 2025, manufacturers have been subject to a new reporting requirement. Manufacturers must notify AEMPS and other competent authorities of supply interruptions or discontinuations that could seriously affect patient care.
Conclusion
Successfully registering a medical device in Spain depends on meeting both EU and national regulatory requirements. And the manufacturers who move through this fastest are usually the ones who understood both sides going in, rather than treating Spain’s national layer as something to figure out once EU conformity was already sorted.
A clear understanding of both EU and national requirements helps streamline the Spain medical device registration process and avoid unnecessary delays. Most delays trace back to documentation, not regulation.
If you’d like help mapping your device’s registration path, reach out to us at info@artixio.com for guidance tailored to your specific device class and entry timeline.
FAQs
Q1. Is CE marking alone sufficient to sell medical devices in Spain?
No. CE Marking for Medical Devices in Spain is a mandatory prerequisite, but manufacturers must also complete a national commercialisation notification to AEMPS for Class IIa, IIb, and III devices. Class I manufacturers established in Spain have additional notification obligations as well.
Q2. What language must medical device documentation be in for Spain?
All device labelling, Instructions for Use (IFUs) and submissions to AEMPS must be provided in Spanish. While technical documentation may be maintained in English for EU MDR purposes, documents submitted to AEMPS upon a reasoned request must be in Spanish, though authorities may accept supporting documentation in other languages.
Q3. Does Spain require ISO 13485 certification for all device classes?
ISO 13485:2016 certification gets checked as part of the QMS assessment for Class IIa, IIb, and III devices. For Class I non-sterile, non-measuring devices, it is not formally required under EU MDR, but it is standard practice and advisable given AEMPS’s active market surveillance approach.
Q4. Are Spain Medical Device Import Requirements different from other EU countries?
Spain Medical Device Import Requirements include a mandatory AEMPS import operating license for entities physically importing devices from outside the EU. This requirement is clarified and extended by Royal Decree 192/2023. This is a Spain-specific national obligation on top of EU MDR importer responsibilities.
